Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan-Reference-Cited by-同舟云学术

Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan

Published:2022-05-17 Issue:5 Volume:66 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Andrade Elaine Silva Nascimento¹²^ORCID,Brandão Jurema Guerrieri¹³,Silva Juliana Souza da¹,Coriolano Carmelita Ribeiro Filha¹,Rosa Patricia Sammarco⁴,Moraes Milton Ozório⁵,Ferreira Cynthia de Oliveira⁶⁷,Gomes Ciro Martins³⁸^ORCID,Araújo Wildo Navegantes de²⁸⁹¹⁰

Affiliation:

1. Coordenação Geral de Doenças em Eliminação – CGDE, Departamento de Doenças de Condições Crônicas e Infecções Sexualmente Transmissíveis – DCCI, Secretaria de Vigilância em Saúde, Ministério da Saúde, Brasília, Brazil

2. Programa de Pós-Graduação em Saúde Coletiva, Faculdade de Medicina, Universidade de Brasília – UnB, Brasília, Brazil

3. Programa de Pós-Graduação em Ciências Médicas, Faculdade de Medicina, Universidade de Brasília – UnB, Brasília, Brazil

4. Laboratório de Biologia Molecular, Instituto Lauro de Souza Lima, Bauru, Brazil

5. Laboratório Hanseníase, Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil

6. Laboratório de Biologia Molecular, Fundação Alfredo da Matta, Manaus, Brazil

7. Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Amazonas, Brazil

8. Programa de Pós-Graduação em Medicina Tropical, Núcleo de Medicina Tropical, Universidade de Brasília – UnB, Brasília, Brazil

9. Faculdade UnB Ceilândia, Universidade de Brasília – UnB, Brasília, Brazil

10. Instituto Nacional de Ciência e Tecnologia para Avaliação de Tecnologia em Saúde, Porto Alegre, Brazil

Abstract

Brazil ranks second among countries for new cases and first for relapse cases of leprosy worldwide. The Mycobacterium leprae Resistance Surveillance Plan was established.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/aac.02170-21

Reference33 articles.

1. The leprosy agents Mycobacterium lepromatosis and Mycobacterium leprae in Mexico

2. World Health Organization. 2020. Global leprosy (Hansen disease) update 2019: time to step-up prevention initiatives. Weekly Epidemiological Record 95:417–440. http://www.who.int/wer.

3. World Health Organization. 2009. Guidelines for global surveillance of drug resistance in Leprosy. WHO Regional Office for South-East Asia New Delhi. https://apps.who.int/iris/handle/10665/205158.

4. Drug Resistance in Leprosy

5. Nested PCR and the TaqMan SNP Genotyping Assay enhanced the sensitivity of drug resistance testing of Mycobacterium leprae using clinical specimens of leprosy patients

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen;Journal of Global Antimicrobial Resistance;2023-12

2. Erratum for Andrade et al., “Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan”;Antimicrobial Agents and Chemotherapy;2023-07-18

3. Effectiveness and safety of multidrug therapy containing clofazimine for paucibacillary leprosy and clarithromycin for rifampicin-resistant leprosy: a systematic review and meta-analysis;Frontiers in Medicine;2023-05-10

4. Antimicrobial resistance and genotyping of Mycobacterium leprae in Venezuela;Frontiers in Tropical Diseases;2023-03-03

5. Hansen's disease (leprosy) in Japan, 1947-2020: an epidemiologic study during the declining phase to elimination;International Journal of Infectious Diseases;2022-12